SEARCH

SEARCH BY CITATION

References

  • 1
    Guidelines for the Clinical Evaluation of Antiepileptic Drugs. Epilepsia 1989;30: 4006.
  • 2
    Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Eng J Med 1985;313: 14551.
  • 3
    Mattson RH, Cramer JA, Collins JF, et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures with secondary generalized tonic-clonic seizures in adults. N Engl J Med 1992;327: 76571.
  • 4
    Jacoby A. Assessing quality of life in patients with epilepsy. PharmacoEconomics 1996;9: 399416.
  • 5
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22: 489501.
  • 6
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 38999.
  • 7
    Johnson T. Statistical methods and clinical trials. In: FreemanC, TyrerP, eds. Research methods in psychiatry: a beginner's guide, 2nd ed. London : Royal College of Psychiatrists, 1992.
  • 8
    Heller AJ, Stewart J, Hughes E, et al. Comparative efficacy and toxicity of phenobarbital, phenytoin, carbamazepine and valproate in adults and children with newly diagnosed previously untreated epilepsy. J Neurol Neurosug Psychiatry 1995;58: 4450.
  • 9
    Jones B, Jarvis P, Lewis JA, et al. Trials to assess equivalence: the importance of rigorous methods. Br Med J 1996;313: 369.
  • 10
    Henry D, Hill S. Comparing treatments. Comparison should be against active treatments rather than placebos. Br Med J 1995;310: 1279.
  • 11
    Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331: 3948.
  • 12
    Temple R. Government viewpoint on clinical trials. Drug Info J 1982; 1: 107.
  • 13
    Hill AB. Medical ethics and controlled trials. Br Med J 1963;1: 10439.
  • 14
    Leber P. Hazards of inference: the active control investigation. Epilepsia 1989;30 (suppl 1):S5763.
  • 15
    Marson AG, Beghi E, Berg A, Chadwick D, Tonini C. The Cochrane collaboration: systematic reviews and their relevance to epilepsy.
  • 16
    Richens A. Rational polypharmacy. Seizure 1995;4: 2114.